AIM@Epilepsy

AI-assisted 4D cortical assessment for Minimally invasive treatment of EPILEPSY

Many patients with epilepsy cannot be treated with drugs or brain surgery. In AIM@EPILEPSY, technology is developed to accurately determine the regions causing the epilepsy, enabling minimally invasive treatment with thermocoagulation or radiotherapy. This is achieved through a collaboration of experts in the fields of neurosurgery, neurology, radiotherapy, medical physics, data science, and health technology.

This project has been awarded funding from the Dutch Research Council (NWO) in 2023, in the KIC call ‘Key enabling technologies for minimally invasive interventions in healthcare’. 

The Project Lead

The Team

Partners

  • Academic Center for Epileptology Kempenhaeghe, Heeze, The Netherlands 
  • CNSprojects, Amsterdam, The Netherlands 
  • Maastricht University, Maastricht, The Netherlands 
  • Maastro Clinic, Maastricht, The Netherlands
  • MUMC+, Maastricht, The Netherlands